(Q38306065)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25555397%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

review article

1 reference

title

Further understanding of tau phosphorylation: implications for therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25555397%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25555397%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Jesús Ávila de Grado

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25555397%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

author name string

Jesús Avila

series ordinal

2

1 reference

2 September 2017

publication date

2 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25555397%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

26 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25555397%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25555397%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25555397%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

115-122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25555397%20AND%20SRC:MED&resulttype=core&format=json

A protein factor essential for microtubule assembly

26 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Tau protein function in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Tau splicing and the intricacies of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Involvement of the carboxyl-terminal domain of tubulin in the regulation of its assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

The microtubule binding domain of tau protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Tau in neurodegenerative diseases: tau phosphorylation and assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Tau protein pathology in neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Differential regulation of dynein and kinesin motor proteins by tau

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

21 January 2018

The many faces of tau

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

The importance of tau phosphorylation for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Functional implications of the association of tau with the plasma membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Tau protein binds single-stranded DNA sequence specifically--the proof obtained in vitro with non-equilibrium capillary electrophoresis of equilibrium mixtures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Nuclear tau, a key player in neuronal DNA protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

New perspectives on the role of tau in Alzheimer's disease. Implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

The influence of phospho-τ on dendritic spines of cortical pyramidal neurons in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Tau pathology and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Genome-wide association study reveals genetic risk underlying Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Modeling of tau-mediated synaptic and neuronal degeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

The in vitro formation of recombinant tau polymers: effect of phosphorylation and glycation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Tau aggregation into fibrillar polymers: taupathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Tau phosphorylation: the therapeutic challenge for neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Diaminothiazoles modify Tau phosphorylation and improve the tauopathy in mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Tau-based treatment strategies in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

The GSK3 hypothesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Recent developments in tau-based therapeutics for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Evidence for irreversible inhibition of glycogen synthase kinase-3β by tideglusib

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Phosphoprotein phosphatase activities in Alzheimer disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

I1PP2A affects tau phosphorylation via association with the catalytic subunit of protein phosphatase 2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Molecular implication of PP2A and Pin1 in the Alzheimer's disease specific hyperphosphorylation of Tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Regulation of protein phosphatase 2A methylation by LCMT1 and PME-1 plays a critical role in differentiation of neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Leucine carboxyl methyltransferase 1 (LCMT1)-dependent methylation regulates the association of protein phosphatase 2A and Tau protein with plasma membrane microdomains in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Tangle-bearing neurons survive despite disruption of membrane integrity in a mouse model of tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Constitutive secretion of tau protein by an unconventional mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Proteostasis of tau. Tau overexpression results in its secretion via membrane vesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Tau elevations in the brain extracellular space correlate with reduced amyloid-β levels and predict adverse clinical outcomes after severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Physiological release of endogenous tau is stimulated by neuronal activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Can Alzheimer disease be prevented by amyloid-beta immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Chaperone-like antibodies in neurodegenerative tauopathies: implication for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Repeated immunization of mice with phosphorylated-tau peptides causes neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Propagation of tau misfolding from the outside to the inside of a cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Transmission and spreading of tauopathy in transgenic mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1000864

10.1586/14737175.2015.1000864

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25555397%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference